Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.
The launch and uptake of more than 20 novel antidiabetic drugs over the next 10 years will drive the type 2 diabetes market to increase by $12.5 billion... More
July 8, 2009... Learn More
See which reports have been searched on the most.
You are now able to download video podcasts to your portable digital media player. These complimentary analyst presentations feature trends and information from our latest reports... Learn More
June 29, 2009
Launch of Targeted Agents and Increased use of Maintenance Therapy Will Drive the Non-Small-Cell Lung Cancer Drug Market to Nearly Triple to Almost $10 Billion in 2018...Read More
June 24, 2009
Availability in Both Intravenous and Oral Formulation is a Leading Drug Attribute Surveyed Physicians Prefer for the Treatment of Urinary Tract Infections in the Hospital Setting...Read More
June 23, 2009
An Increase in the Diagnosed Prevalent Population Will Drive Growth of Nearly $4.3 Billion in the Chronic Obstructive Pulmonary Disease Market...Read More
Rheumatoid Arthritis
The rheumatoid arthritis (RA) therapy market has matured to the point that TNF-a inhibitors are firmly established as fi... Read More
Vytorin One Year On: How Will Prescriber Attitudes and Payer Hurdles Influence the Markets for Dyslipidemia?
Merck/Schering-Plough’s blockbuster antidyslipidemic drugs, Vytorin and Zetia, suffered a major blow when results fro... Read More
Pharmaceutical Pricing and Reimbursement in China
With a growth rate of more than 20% per year, the Chinese pharmaceutical market is set to become the third largest in th... Read More